Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients

PGM3 deficient patients have impaired STAT3 signaling downstream of the highly glycosylated protein gp130, thereby constituting the mechanistic basis for the clinical features shared by STAT3-, gp130- and PGM3-deficient patients.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Bt8R5Z